Award recordCONTRACT

ROCHE DIAGNOSTICS CORPORATION

PIID 36C26126P0448· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2026· $120,976 net obligations· UEI JDMDFEZBYH36· IN

Description

EO 14398 REQUIREMENT

Base award description: B+4 CPT CLINICAL IMMUNOHISTOCHEMISTRY AND IN-SITU HYBRIDIZATION

First action · last action
2026-03-11 · 2026-07-20
Transactions
2
First transaction's obligation
$120,976
Base + all options value (sum of deltas)
$604,881
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$120,976$0Base award · 2026-03-11 · this action $120,976 · running total $120,976Modification P00001 · 2026-07-20 · this action $0 · running total $120,976
  • Base2026-03-11+$120,976= $120,976
  • Mod P000012026-07-20+$0= $120,976
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-03-11+$120,976$120,976B+4 CPT CLINICAL IMMUNOHISTOCHEMISTRY AND IN-SITU HYBRIDIZATION
Mod P00001· OTHER ADMINISTRATIVE ACTION2026-07-20+$0$120,976EO 14398 REQUIREMENT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JDMDFEZBYH36)

AwardOffice · PSC / listingNet obligationsFY
36C25026N0794250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$200,000FY2026
36C25026N0788250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$135,282FY2026
36C25726N0474257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$21,384FY2026
36C25726C0089257-NETWORK CONTRACT OFFICE 17 (36C257) · J066 · MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT$46,948FY2026
36C25926N0437NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$35,030FY2026
36C25926N0438NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$34,878FY2026

Other recipients under 6550 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126N0364BIOMERIEUX INC261-NETWORK CONTRACT OFFICE 21 (36C261)$112,848FY2026
36C26126N0371RLS (USA) INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$250,075FY2026
36C26126P0353HEMOSONICS, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$82,300FY2026
36C26126F0102WERFEN USA LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$79,671FY2026
36C26126N0128CEPHEID261-NETWORK CONTRACT OFFICE 21 (36C261)$1,084,961FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26126P0448_3600_-NONE-_-NONE- · retrieved 2026-09-26.